Clinatec seeks €30 million to combat neurodegenerative diseases, cancer and ailments that cause handicaps

, Lire cette page en français , Share

The biomedical research center, Clinatec, recently launched an international campaign to collect €30 million within the next five years. Clinatec, which was created through the collaborative efforts of CEA, the CHU of Grenoble and Inserm, is a neuro-clinic that specializes in therapeutic medical innovations that combine micro-nanotechnologies and electronics. Clinatec plans to invest the money that it will collect in projects aimed towards finding solutions to neurodegenerative diseases, cancer and ailments that cause motor disabilities.

For more information, read the press release:

« Clinatec Announces €30M Fundraising Campaign to Speed Research In Treatment of Neurodegenerative Diseases, Cancer and Motor Disabilities »
PDF - 299.9 kb